The Sterile Hypodermic Syringes for Single Use are intended to be used for medical purposes on adult and pediatric population to inject fluids into or withdraw fluids from the body.

Device Description

The Sterile Hypodermic Syringe for Single Use is intended for single use only, which consists of barrel, plunger and piston. The proposed device is available in a variety syringe volume. The syringe is available in luer slip and luer lock two connector types which are intended to be connected with a hypodermic needle.

AI/ML Overview

The provided text is a 510(k) summary for a medical device (Sterile Hypodermic Syringe for Single Use) and does not contain information about acceptance criteria and study details as typically found for AI/ML-based medical devices. The document focuses on demonstrating substantial equivalence to a predicate device based on non-clinical performance, material comparisons, and adherence to recognized standards.

Therefore, I cannot provide a table of acceptance criteria and reported device performance, nor details about sample sizes for test sets, data provenance, expert ground truth establishment, adjudication methods, MRMC studies, standalone performance, or training set specifics, as these are not discussed in the provided text.

The document primarily outlines:

Device Description: Sterile Hypodermic Syringe for Single Use, consisting of a barrel, plunger, and piston, available in various volumes and luer slip/luer lock connector types.
Indication for Use: Intended for medical purposes on adult and pediatric populations to inject fluids into or withdraw fluids from the body.
Predicate Device: K210227, Sterile syringe for single use with/without needle.
Comparison to Predicate: Differences noted include volume specifications, piston material (Polyisoprene Rubber vs. Silicone Rubber), patient population explicit mention, and shelf-life (5 years vs. 3 years). These differences are argued not to affect safety and effectiveness.
Non-Clinical Test Performance Testing: The device was tested for conformance with:
- ISO 7886-1:2017 (Sterile hypodermic syringes for single use)
- ISO 80369-7: 2016 (Small-bore connectors for liquids and gases in healthcare applications)
- Biocompatibility Testing (ISO 10993-1): Cytotoxicity, Sensitization, Intracutaneous Reactivity Test, Acute Systemic Toxicity, Hemocompatibility, Pyrogenicity.
- Particulate Matter Testing: USP <788>.
- Sterile Barrier Packaging Test: Visual inspection (ASTM F1886/F1886M-16), seal strength (ASTM F88/F88-15), and dye penetration test (ASTM F1929-15).
- Sterilization and Shelf Life Test: Validated per ISO 11135, including EO residue, ECH residue (ISO 10993-7:2008), Bacteria Endotoxin Limit (USP <85>), and Shelf Life Evaluation (physical, mechanical, chemical, package tests on aging samples).

The document declares that the device is substantially equivalent to the predicate based on these non-clinical tests and comparisons. It does not involve AI/ML components or the types of studies typically associated with such technologies.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

May 12, 2022

BERPU MEDICAL TECHNOLOGY CO., LTD Buxin Yu Management Representative No.14 Xingii Road, Yongxing Street Longwan District, 325000, Wenzhou, Zhejiang Province

Re: K213811

Trade/Device Name: Sterile Hypodermic Syringes For Single Use Regulation Number: 21 CFR 880.5860 Regulation Name: Piston syringe Regulatory Class: Class II Product Code: FMF Dated: February 2, 2022 Received: April 4, 2022

Dear Buxin Yu:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

For CAPT Alan Stevens Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K213811

Device Name

Sterile Hypodermic Syringe for Single Use

Indications for Use (Describe)

The Sterile Hypodermic Syringes for Single Use are intended to be used for medical purposes on adult and pediatric population to inject fluids into or withdraw fluids from the body.

Type of Use (Select one or both, as applicable)
-------------------------------------------------	--

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

K213811 510(k) Summary

1. Date of Preparation: May 7, 2022

2. Sponsor Identification

BERPU MEDICAL TECHNOLOGY CO., LTD NO.14 Xingji Road, Yongxing Street, Longwan District, 325000, Wenzhou, Zhejiang Province

Establishment Registration Number: 3004496829

Contact Person: Buxin Yu Position: Management Representative Tel: +86-577-86651999 Fax: +86-577-86630389 Email: zhc@berpu.com

3. Identification of Proposed Device

Trade Name: Sterile Hypodermic Syringe for Single Use

Regulatory Information Classification Name: Piston Syringe Classification: II Product Code: FMF Regulation Number: 21 CFR 880.5860 Review Panel: General Hospital

4. Identification of Predicate Devices

Predicate Device 510(k) Number: K210227 Product Name: Sterile syringe for single use with/without needle

5. Device Description

{4}------------------------------------------------

Characteristic	Predicate Device	Subject Device
Sterile syringe for single usewith/without needleK210227	Sterile Hypodermic Syringes for SingleUseK213811
Indication for Use	The Sterile Syringes for Single Usewith/without needle are intended to beused for medical purposes on adultand inject inject fluids into or withdrawfluids from the body.	The Sterile Hypodermic Syringes forSingle Use are intended to be used formedical purposes on adult and pediatricpopulation to inject fluids into orwithdraw fluids from the body.

6. Indication for Use

The indications for use of the subject device are slightly different from the predicate device. The difference is the intended population is included in the indications of subject device. This difference is does not affect safety and effectiveness of the proposed device.

Substantially Equivalent (SE) Comparison 7.

Table 2 Comparison of Technology Characteristics of Sterile Hypodermic Syringes for Single Use

Item	Proposed DeviceK213811	Predicate DeviceK210227	Remark
Product name	Sterile Hypodermic Syringesfor Single Use	Sterile syringe for single usewith/without needle	-
Product Code	FMF	FMF	same
Regulation No.	21 CFR 880.5860	21 CFR 880.5860	Same
Class	CLASS II	CLASS II	same
Syringe volume	10ml, 20ml, 30ml, 50mL, 60ml	1ml, 2ml, 3ml, 5ml, 10ml,20ml, 30ml, 50ml, 60ml,100ml	Analysis 1
Nozzle type	Luer slip; Luer lock	Luer slip; Luer lock	same
Configuration andmaterial	BarrelPolypropylene(PP)	BarrelPolypropylene(PP)
	PlungerPolypropylene(PP)	PlungerPolypropylene(PP)	Analysis 2
	PistonPolyisopreneRubber	PistonSiliconeRubber
Operation Mode	For manual use only	For manual use only	same
Syringe Performance	Complied with ISO7886-1:2017	Complied with ISO7886-1:2017	same
Biocompatibility	Comply with ISO 10993 seriesstandards, which includes:	Comply with ISO 10993 seriesstandards, which includes:	same

{5}------------------------------------------------

	ISO 10993-5: 2009;	ISO 10993-5: 2009;
	ISO 10993-10: 2010	ISO 10993-10: 2010
	ISO 10993-4: 2017	ISO 10993-4: 2017
	ISO 10993-11: 2017	ISO 10993-11: 2017
OTC use	No	No	same
Single for Use	Yes	Yes	same
Patient population	Adult and children	unknown	Analysis 3
Shelf-life	5 years	3 years	Analysis 4
Sterilization	EO Sterilization	EO Sterilization	same
SAL	10-6	10-6	same
Label/Labeling	Complied with 21 CFR part801	Complied with 21 CFR part801	same

Analysis 1- Syringe volume

The proposed has less specification of syringe volume compared to predicate device. However, the different syringe volume will be selected by physician per injection requirement and this difference does not affect intended use. In addition, the syringe volume for proposed device is covered by predicate device. The performance of the proposed devices has been performed on the final finished device. The test results shows passed the requirements of standard of ISO 7886-1. Therefore, this difference is not considered to affect the Substantially Equivalency (SE) between the proposed and predicate devices.

Analysis 2-Configuration and material

The configurations for both proposed device and predicate device are similar, the difference is just in component material. However, the biocompatibility test result does not show any adverse effect which can demonstrate the safety of proposed device. Therefore, this difference is not considered to affect substantially equivalence.

Analysis 3-Paptient population

This difference does not alter suitability of the proposed device for its intended use

Analysis 4-Shelf-life

The shelf life of the proposed device is 5 years, which is longer than the predicated device. The product performance after 5 years has been determined based on accelerated aging study. The packaging integrity test of proposed device was conducted on the proposed device. The results can demonstrate that the packaging was able to maintain sterility of the sterilized finished device during its shelf life of 5 years.

8. Non-Clinical Test Performance Testing

The Sterile Hypodermic Syringe for Single Use described in this summary were tested and demonstrated to be in conformance with the following FDA recognized standards:

. ISO 7886 -1:2017 Sterile hypodermic syringes for single use -- Part 1: Syringes for manual use

{6}------------------------------------------------

. ISO 80369-7: 2016 Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications

Biocompatibility Testing:

In accordance with ISO 10993-1, the syringe is classified as: Externally communicating Device. Blood Path Indirect, Limited Contact (<24hours). The proposed device was evaluated for the following tests. The results for the biocompatibility testing showed that there are no negative impacts from the materials that are used in the proposed device.

. Cytotoxicity
. Sensitization
Intracutaneous Reactivity Test .
Acute Systemic Toxicity .
Hemocompatibility
. Pyrogenicity

Particulate matter testing was conducted in accordance with USP <788> Particulate Matter in Injections and met the USP acceptance criteria.

Sterile Barrier Packaging Test

Sterile barrier packaging testing were performed on the proposed device, which include visual inspection (ASTM F1886/F1886M-16), seal strength (ASTM F88/F88-15) and dye penetration test (ASTM F1929-15). The test result showed that the device package can maintain its integrity.

Sterilization and Shelf Life Test

The sterilization method has been validated per ISO 11135, which has thereby determined the routine control and monitoring parameters. The shelf life of the Sterile Hypodermic Syringe for Single Use is 5 years, determined based on stability studies which includes accelerated aging.

Sterilization and shelf life testing listed were performed on the proposed device.

Item	Standard
EO residue	ISO 10993-7:2008
ECH residue	ISO 10993-7:2008
Bacteria Endotoxin Limit	USP <85>
Shelf Life Evaluation	Physical, Mechanical, Chemical, Package Tests were performed onaging samples to verify the claimed shelf life of the device

9. Conclusion

The differences between the predicate and the subject device do not raise any new or different questions of safety or effectiveness. The Sterile Hypodermic Syringes for Single Use is substantially equivalent to the Sterile Syringe for Single Use with/without Needle with respect to the indications for use, target populations, treatment method, and technological characteristics.

Regulation Number and Section

§ 880.5860 Piston syringe.

(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).